Login
$CTXR
$0.50 +$0.05 (11.62%) Close

Insider Transactions

What Citius Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Holuka Eugene Myron Director Mar 13 Withheld — tax / exercise cost · F −48 $0.75 −$36 2,367
Holuka Eugene Myron Director Mar 13 Exercise / conversion · M +2,415 $0.02 +$36.2 2,415
Webb Carol Director Mar 04 Withheld — tax / exercise cost · F −236 $0.77 −$181 11,835
Webb Carol Director Mar 04 Exercise / conversion · M +12,071 $0.02 +$181 12,071
Holubiak Myron Z President and CEO Sep 27 Open-market buy · P +558,597 $0.90 +$500K 1,992,243
Mazur Leonard L Executive Chairman Sep 27 Open-market buy · P +2,234,700 $0.90 +$2M 10,255,343
Holubiak Myron Z President and CEO Apr 03 Open-market buy · P +129,450 $1.55 +$200K 1,433,646
Mazur Leonard L Executive Chairman Apr 03 Open-market buy · P +1,165,048 $1.55 +$1.8M 8,020,643
Holubiak Myron Z President and CEO Aug 13 Open-market buy · P +784,314 $1.28 +$1M 1,304,196
Mazur Leonard L Executive Chairman Aug 13 Open-market buy · P +3,137,255 $1.28 +$4M 6,855,595
Mazur Leonard L Executive Chairman Mar 29 Open-market buy · P +167,504 $2.99 +$500K 3,718,340
Holubiak Myron Z President and CEO Mar 28 Open-market buy · P +2,915 $3.09 +$9.01K 519,882
Mazur Leonard L Executive Chairman Dec 19 Open-market buy · P +213,106 $4.69 +$999K 3,550,836
Mazur Leonard L Executive Chairman Aug 24 Open-market buy · P +11,000 $2.68 +$29.5K 3,337,730
Mazur Leonard L Executive Chairman Aug 08 Derivative Conversion · C +1,547,067 $3.09 +$4.78M 3,326,730
Mazur Leonard L Executive Chairman Aug 08 Open-market buy · P +421,400 $4.13 +$1.74M 1,779,663
Holubiak Myron Z President and CEO Mar 30 Other Transaction · J +7,754,497 — — 7,754,497
Mazur Leonard L Director Mar 30 Other Transaction · J +15,116,746 — — 20,116,746
Mazur Leonard L Director Mar 30 Open-market buy · P +5,000,000 $0.60 +$3M 5,457,143

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support